Skip to main content
Livermore
Livermore
ZHEN

Wealthfront Advisers LLC

SEC CIK
0001763921
Latest filing
Aug 7, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
6,440
Value
$2.31M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of WST by Wealthfront Advisers LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,440$2.31M<0.1%+937+17.0%AddedHolders
Q1 20265,503$1.38M<0.1%+24+0.4%AddedHolders
Q4 20255,479$1.51M<0.1%+1,007+22.5%AddedHolders
Q3 20254,472$1.17M<0.1%+1,765+65.2%AddedHolders
Q2 20252,707$592.3K<0.1%−864−24.2%ReducedHolders
Q1 20253,571$799.5K<0.1%−1,109−23.7%ReducedHolders
Q4 20244,680$1.53M<0.1%+1,065+29.5%AddedHolders
Q3 20243,615$1.09M<0.1%−659−15.4%ReducedHolders
Q2 20244,274$1.41M<0.1%−2,345−35.4%ReducedHolders
Q1 20246,619$2.62M<0.1%−1,701−20.4%ReducedHolders
Q4 20238,320$2.93M<0.1%+3,520+73.3%AddedHolders
Q3 20234,800$1.80M<0.1%+59+1.2%AddedHolders
Q2 20234,741$1.81M<0.1%−25−0.5%ReducedHolders
Q1 20234,766$1.65M<0.1%+593+14.2%AddedHolders
Q4 20224,173$982.1K<0.1%+800+23.7%AddedHolders
Q3 20223,373$830.0K<0.1%−2,655−44.0%ReducedHolders
Q2 20226,028$1.82M<0.1%−752−11.1%ReducedHolders
Q1 20226,780$2.79M<0.1%+1,011+17.5%AddedHolders
Q4 20215,769$2.71M<0.1%−197−3.3%ReducedHolders
Q3 20215,966$2.53M<0.1%+77+1.3%AddedHolders
Q2 20215,889$2.12M<0.1%−366−5.9%ReducedHolders
Q1 20216,255$1.76M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.